Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             285 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A cost–effectiveness analysis of Japanese encephalitis vaccine in Cambodia Touch, Sok
2010
28 Supplement 1 p. 4593-4599
7 p.
artikel
2 Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth Bruder, Joseph T.
2010
28 Supplement 1 p. 3201-3210
10 p.
artikel
3 Adjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: Different effects on cellular and humoral immunity Ganguly, Sumita
2010
28 Supplement 1 p. 1300-1309
10 p.
artikel
4 Administration of dendritic cells dual expressing DcR3 and GAD65 mediates the suppression of T cells and induces long-term acceptance of pancreatic-islet transplantation Li, Qiansheng
2010
28 Supplement 1 p. 8300-8305
6 p.
artikel
5 Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009–January 31, 2010 Vellozzi, Claudia
2010
28 Supplement 1 p. 7248-7255
8 p.
artikel
6 A field study evaluating health, performance, and behavior differences in crossbred beef calves administered different vaccine-parasiticide product combinations Hanzlicek, Gregg A.
2010
28 Supplement 1 p. 5998-6005
8 p.
artikel
7 Age-dependent association between IgG2 and IgG3 subclasses to Pf332-C231 antigen and protection from malaria, and induction of protective antibodies by sub-patent malaria infections, in Daraweesh Giha, Hayder A.
2010
28 Supplement 1 p. 1732-1739
8 p.
artikel
8 Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children Passwell, Justen H.
2010
28 Supplement 1 p. 2231-2235
artikel
9 A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity Smallshaw, Joan E.
2010
28 Supplement 1 p. 2428-2435
8 p.
artikel
10 A Mage3/Heat Shock Protein70 DNA vaccine induces both innate and adaptive immune responses for the antitumor activity Wang, Lifeng
2009
28 Supplement 1 p. 561-570
10 p.
artikel
11 An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response Hu, Xi-Dan
2010
28 Supplement 1 p. 2408-2415
8 p.
artikel
12 A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates Bartlett, Emmalene J.
2010
28 Supplement 1 p. 767-779
13 p.
artikel
13 A novel mitogen fusion protein against CD40+ cells with potent vaccine adjuvant properties Yoshida, Tetsuya
2010
28 Supplement 1 p. 3688-3695
8 p.
artikel
14 A novel therapeutic vaccine of GM-CSF/TNFα surface-modified RM-1 cells against the orthotopic prostatic cancer Yin, Weihua
2010
28 Supplement 1 p. 4937-4944
8 p.
artikel
15 Antibody persistence in young adults 1 year after MMR immunization by aerosol or by subcutaneous route Díaz-Ortega, José Luis
2010
28 Supplement 1 p. 7228-7232
5 p.
artikel
16 Antibody persistence six years after two doses of combined hepatitis A and B vaccine Burgess, Margaret A.
2010
28 Supplement 1 p. 2222-2226
artikel
17 Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity Vaine, Michael
2010
28 Supplement 1 p. 2999-3007
9 p.
artikel
18 Antibody response to influenza immunization in coronary artery disease patients: A controlled trial Keshtkar-Jahromi, Maryam
2009
28 Supplement 1 p. 110-113
4 p.
artikel
19 Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation Hirosue, Sachiko
2010
28 Supplement 1 p. 7897-7906
10 p.
artikel
20 Anti-preS responses influence the anti-HBs response in newborns after vaccination with the third generation Sci-B-Vac™ vaccine Sylvan, Staffan P.E.
2009
28 Supplement 1 p. 446-451
6 p.
artikel
21 A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA Keiser, Paul B.
2010
28 Supplement 1 p. 6970-6976
7 p.
artikel
22 A preliminary study of chemo- and cytokine responses in rabies vaccine recipients of intradermal and intramuscular regimens Saraya, Abhinbhen
2010
28 Supplement 1 p. 4553-4557
5 p.
artikel
23 A randomized controlled trial of analgesia during vaccination in adults Taddio, Anna
2010
28 Supplement 1 p. 5365-5369
5 p.
artikel
24 A randomized controlled trial of low-dose recombinant human interferons α-2b nasal spray to prevent acute viral respiratory infections in military recruits Gao, LuLu
2010
28 Supplement 1 p. 4445-4451
7 p.
artikel
25 A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice Gentil, Fernanda
2010
28 Supplement 1 p. 6183-6190
8 p.
artikel
26 Are hard-to-reach populations being reached with immunization services? Findings from the 2005 Papua New Guinea national immunization coverage survey Toikilik, Steven
2010
28 Supplement 1 p. 4673-4679
7 p.
artikel
27 Are young injection drug users ready and willing to participate in preventive HCV vaccine trials? Levy, Vivian
2010
28 Supplement 1 p. 5947-5951
5 p.
artikel
28 A steady-state, population-based model to estimate the direct and indirect effects of pneumococcal vaccines Talbird, Sandra E.
2010
28 Supplement 1 p. G3-G13
nvt p.
artikel
29 A systematic review of measures for reducing injection pain during adult immunization Hogan, Mary-Ellen
2010
28 Supplement 1 p. 1514-1521
8 p.
artikel
30 A therapeutic DNA vaccination strategy for autoimmunity and transplantation Li, Alice
2010
28 Supplement 1 p. 1897-1904
8 p.
artikel
31 Attenuation of defined Brucella melitensis wboA mutants Nikolich, Mikeljon P.
2010
28 Supplement 1 p. F12-F16
nvt p.
artikel
32 A universal anti-HIV-1 Tat epitope vaccine that is fully synthetic and self-adjuvanting Goldstein, Gideon
2010
28 Supplement 1 p. 1008-1014
7 p.
artikel
33 A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus Van de Walle, Gerlinde R.
2010
28 Supplement 1 p. 1048-1055
8 p.
artikel
34 A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children Zhu, Wei
2010
28 Supplement 1 p. 2865-2876
12 p.
artikel
35 A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine Puthanakit, Thanyawee
2010
28 Supplement 1 p. 5900-5902
3 p.
artikel
36 Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: Response to Misleading comments in Ranganathan et al. “Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice” Larsen, Michelle H.
2010
28 Supplement 1 p. 3633-3634
2 p.
artikel
37 Biochemical characterizations of Escherichia coli-expressed protective antigen Ag473 of Neisseria meningitides group B Sung, Jerry Wang-Chou
2010
28 Supplement 1 p. 8175-8182
8 p.
artikel
38 Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation Bråve, Andreas
2010
28 Supplement 1 p. 8203-8209
7 p.
artikel
39 Bottleneck effects on vaccine-candidate antigen diversity of malaria parasites in Thailand Jongwutiwes, Somchai
2010
28 Supplement 1 p. 3112-3117
6 p.
artikel
40 Carbohydrate moieties as vaccine candidates: Meeting summary Lucas, A.H.
2010
28 Supplement 1 p. 1121-1131
11 p.
artikel
41 Cell-mediated immune response and cross-protective efficacy of binary ethylenimine-inactivated bluetongue virus serotype-1 vaccine in sheep Umeshappa, Channakeshava Sokke
2010
28 Supplement 1 p. 2522-2531
10 p.
artikel
42 Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34kDa rhoptry antigen (Pv34) Mongui, Alvaro
2009
28 Supplement 1 p. 415-421
7 p.
artikel
43 Characterization of murine T-cell epitopes on mycobacterial DNA-binding protein 1 (MDP1) using DNA vaccination Suzuki, Daisuke
2010
28 Supplement 1 p. 2020-2025
6 p.
artikel
44 Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity Barnoy, S.
2010
28 Supplement 1 p. 1642-1654
13 p.
artikel
45 Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine Pöllabauer, Eva Maria
2010
28 Supplement 1 p. 4558-4565
8 p.
artikel
46 Co-administration of viral vector-based vaccines suppresses antigen-specific effector CD8 T cells Yashima, Sayaka
2010
28 Supplement 1 p. 3257-3264
8 p.
artikel
47 Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines Steele, A.D.
2010
28 Supplement 1 p. 6542-6548
7 p.
artikel
48 Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine Oura, C.A.L.
2010
28 Supplement 1 p. 2749-2753
5 p.
artikel
49 Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens Lee, Lucy F.
2010
28 Supplement 1 p. 1294-1299
6 p.
artikel
50 Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques Livingston, Brian D.
2010
28 Supplement 1 p. 1056-1061
6 p.
artikel
51 Comparative varicella vaccine effectiveness during outbreaks in day-care centres Spackova, M.
2010
28 Supplement 1 p. 686-691
6 p.
artikel
52 Comparison of immunogenicity and safety between two paediatric TBE vaccines Pöllabauer, Eva Maria
2010
28 Supplement 1 p. 4680-4685
6 p.
artikel
53 Comparison of long-term humoral memory development after immunisation against Neisseria meningitidis B or diphtheria toxoid Cruz, Simone C.
2010
28 Supplement 1 p. 6841-6846
6 p.
artikel
54 Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents Beran, Jiri
2010
28 Supplement 1 p. 5993-5997
5 p.
artikel
55 Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model Sabarth, Nicolas
2010
28 Supplement 1 p. 650-656
7 p.
artikel
56 Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans Bett, Andrew J.
2010
28 Supplement 1 p. 7881-7889
9 p.
artikel
57 Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2–10 years of age Halperin, Scott A.
2010
28 Supplement 1 p. 7865-7872
8 p.
artikel
58 Complex cytokine profiles induced by BCG vaccination in UK infants Lalor, Maeve K.
2010
28 Supplement 1 p. 1635-1641
7 p.
artikel
59 Constitutive expression of HIV-VLPs in stably transfected insect cell line for efficient delivery system Tagliamonte, M.
2010
28 Supplement 1 p. 6417-6424
8 p.
artikel
60 Construction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strains Hidajat, Rachmat
2010
28 Supplement 1 p. 3963-3971
9 p.
artikel
61 Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein Reszka, Natalia J.
2010
28 Supplement 1 p. 2754-2762
9 p.
artikel
62 Construction of a triple modified p53 containing DNA vaccine to enhance processing and presentation of the p53 antigen Hospers, Geke A.P.
2009
28 Supplement 1 p. 386-391
6 p.
artikel
63 Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice Zhang, Guohong
2010
28 Supplement 1 p. 7243-7247
5 p.
artikel
64 Contribution of Cyclophilin A to determination of simian immunodeficiency virus tropism: A progress update Takeuchi, Hiroaki
2010
28 Supplement 1 p. B51-B54
nvt p.
artikel
65 Control of EHV-1 viremia and nasal shedding by commercial vaccines Goehring, L.S.
2010
28 Supplement 1 p. 5203-5211
9 p.
artikel
66 Control of Salmonella Enteritidis and Salmonella Gallinarum in birds by using live vaccine candidate containing attenuated Salmonella Gallinarum mutant strain Penha Filho, Rafael Antonio Casarin
2010
28 Supplement 1 p. 2853-2859
7 p.
artikel
67 Corrigendum to “Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants” Vaccine 15 (1997) 265–272 Rencher, Samantha D.
2010
28 Supplement 1 p. 3507-
1 p.
artikel
68 Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine Stittelaar, Koert J.
2010
28 Supplement 1 p. 4970-4976
7 p.
artikel
69 Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant Sui, Zhiwei
2010
28 Supplement 1 p. 7690-7698
9 p.
artikel
70 Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan Huang, Wan-Ting
2010
28 Supplement 1 p. 7161-7166
6 p.
artikel
71 Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus Whiteman, Melissa C.
2010
28 Supplement 1 p. 1075-1083
9 p.
artikel
72 Development and statistical validation of a guinea pig model for vaccine potency testing against Infectious Bovine Rhinothracheitis (IBR) virus Parreño, Viviana
2010
28 Supplement 1 p. 2539-2549
11 p.
artikel
73 Development of a nasal adenovirus-based vaccine: Effect of concentration and formulation on adenovirus stability and infectious titer during actuation from two delivery devices Renteria, Sandra S.
2010
28 Supplement 1 p. 2137-2148
12 p.
artikel
74 Development of an 8-plex Luminex assay to detect swine cytokines for vaccine development: Assessment of immunity after porcine reproductive and respiratory syndrome virus (PRRSV) vaccination Lawson, Steven
2010
28 Supplement 1 p. 5356-5364
9 p.
artikel
75 Differential activation of host cell signalling pathways through infection with two variants of influenza A/Puerto Rico/8/34 (H1N1) in MDCK cells Heynisch, B.
2010
28 Supplement 1 p. 8210-8218
9 p.
artikel
76 Differential identification of Chlamydophila abortus live vaccine strain 1B and C. abortus field isolates by PCR-RFLP Laroucau, Karine
2010
28 Supplement 1 p. 5653-5656
4 p.
artikel
77 Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper Chandran, Dev
2009
28 Supplement 1 p. 132-139
8 p.
artikel
78 Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from disease Craigo, Jodi K.
2010
28 Supplement 1 p. 8095-8104
10 p.
artikel
79 DNA-mediated vaccination conferring protection against infectious bursal disease in broiler chickens in the presence of maternal antibody Hsieh, Ming Kun
2010
28 Supplement 1 p. 3936-3943
8 p.
artikel
80 DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge Kask, Angela Shaulov
2010
28 Supplement 1 p. 7483-7491
9 p.
artikel
81 DNA vaccine expressing HIV-1 gp120/immunoglobulin fusion protein enhances cellular immunity Shimada, Masaru
2010
28 Supplement 1 p. 4920-4927
8 p.
artikel
82 DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells Kim, Daejin
2010
28 Supplement 1 p. 7297-7305
9 p.
artikel
83 Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI® Vilaplana, C.
2010
28 Supplement 1 p. 1106-1116
11 p.
artikel
84 Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan de Blasio, Birgitte Freiesleben
2010
28 Supplement 1 p. 7923-7932
10 p.
artikel
85 Dynamics of memory and naïve CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rγnull mice infected with CCR5-tropic HIV-1 Sato, Kei
2010
28 Supplement 1 p. B32-B37
nvt p.
artikel
86 Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme Harboe, Zitta B.
2010
28 Supplement 1 p. 2642-2647
6 p.
artikel
87 Editorial Board 2010
28 Supplement 1 p. CO2-
1 p.
artikel
88 Editorial Board 2010
28 Supplement 1 p. CO2-
1 p.
artikel
89 Editorial Board 2010
28 Supplement 1 p. CO2-
1 p.
artikel
90 Editorial Board 2010
28 Supplement 1 p. CO2-
1 p.
artikel
91 Editorial Board 2010
28 Supplement 1 p. CO2-
1 p.
artikel
92 Editorial Board 2010
28 Supplement 1 p. CO2-
1 p.
artikel
93 Editorial Board 2010
28 Supplement 1 p. CO2-
1 p.
artikel
94 Editorial Board 2010
28 Supplement 1 p. CO2-
1 p.
artikel
95 Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1 Gwinn, William M.
2010
28 Supplement 1 p. 6901-6914
14 p.
artikel
96 Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: Role of CD4+ and CD8+ T cells Limon-Flores, Alberto Yairh
2010
28 Supplement 1 p. 7414-7419
6 p.
artikel
97 Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study Palmer, Liisa A.
2010
28 Supplement 1 p. 5049-5056
8 p.
artikel
98 Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination Soh, Shu E
2010
28 Supplement 1 p. 2577-2579
3 p.
artikel
99 Effects of astragalus polysaccharides on immunologic function of erythrocyte in chickens infected with infectious bursa disease virus Jiang, Junbing
2010
28 Supplement 1 p. 5614-5616
3 p.
artikel
100 Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes Wu, J.
2010
28 Supplement 1 p. 2775-2781
7 p.
artikel
101 Efficiency of inactivated vaccines against heartwater in Burkina Faso: Impact of Ehrlichia ruminantium genetic diversity Adakal, Hassane
2010
28 Supplement 1 p. 4573-4580
8 p.
artikel
102 Elicitation of broad CTL response against HIV-1 by the DNA vaccine encoding artificial multi-component fusion protein MultiHIV—Study in domestic pigs Mölder, Tarmo
2009
28 Supplement 1 p. 293-298
6 p.
artikel
103 Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10 Da’dara, Akram A.
2010
28 Supplement 1 p. 1310-1317
8 p.
artikel
104 Embryo vaccination of chickens using a novel adjuvant formulation stimulates protective immunity against Eimeria maxima infection Lee, Sung-Hyen
2010
28 Supplement 1 p. 7774-7778
5 p.
artikel
105 Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens Li, Lijin
2010
28 Supplement 1 p. 1911-1918
8 p.
artikel
106 Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield Chung, Cheng-Yu
2010
28 Supplement 1 p. 6951-6957
7 p.
artikel
107 Epidemiological study of Brucellosis in cattle, immunized with Brucella abortus RB51 vaccine in endemic zones Herrera-López, Enrique
2010
28 Supplement 1 p. F59-F63
nvt p.
artikel
108 Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects Sather, D. Noah
2010
28 Supplement 1 p. B8-B12
nvt p.
artikel
109 Evaluation of hepatic changes and local and systemic immune responses in goats immunized with recombinant Peroxiredoxin (Prx) and challenged with Fasciola hepatica Mendes, Ricardo E.
2010
28 Supplement 1 p. 2832-2840
9 p.
artikel
110 Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle Wäckerlin, Regula
2010
28 Supplement 1 p. 4348-4355
8 p.
artikel
111 Evaluation of live-attenuated Salmonella vaccines expressing Campylobacter antigens for control of C. jejuni in poultry Buckley, Anthony M.
2010
28 Supplement 1 p. 1094-1105
12 p.
artikel
112 Evaluation of particulate acellular vaccines against Brucella ovis infection in rams Da Costa Martins, Raquel
2010
28 Supplement 1 p. 3038-3046
9 p.
artikel
113 Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep Dungu, Baptiste
2010
28 Supplement 1 p. 4581-4587
7 p.
artikel
114 Evaluation of the immune response and protective effects of rhesus macaques vaccinated with biodegradable nanoparticles carrying gp120 of human immunodeficiency virus Himeno, Ai
2010
28 Supplement 1 p. 5377-5385
9 p.
artikel
115 Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys Pichyangkul, S.
2009
28 Supplement 1 p. 452-462
11 p.
artikel
116 Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development Franco, David
2010
28 Supplement 1 p. 5676-5685
10 p.
artikel
117 Experimental iron-inactivated Pasteurella multocida A: 1 vaccine adjuvanted with bacterial DNA is safe and protects chickens from fowl cholera Herath, Chitra
2010
28 Supplement 1 p. 2284-2289
6 p.
artikel
118 Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses Almeida, Coral-Ann M.
2010
28 Supplement 1 p. 6052-6057
6 p.
artikel
119 Expression, purification and characterization of allelic variants of MSP-142 from Indian Plasmodium falciparum isolates Lalitha, P.V.
2010
28 Supplement 1 p. 4661-4667
7 p.
artikel
120 Factors influencing HPV vaccination status in a Latino population; and parental attitudes towards vaccine mandates Yeganeh, Nava
2010
28 Supplement 1 p. 4186-4191
6 p.
artikel
121 Feasibility of single-shot H5N1 influenza vaccine in ferrets, macaques and rabbits Heldens, J.G.M.
2010
28 Supplement 1 p. 8125-8131
7 p.
artikel
122 Flow cytometric assessment of chicken T cell-mediated immune responses after Newcastle disease virus vaccination and challenge Dalgaard, T.S.
2010
28 Supplement 1 p. 4506-4514
9 p.
artikel
123 Folding domains within the ricin toxin A subunit as targets of protective antibodies O’Hara, Joanne M.
2010
28 Supplement 1 p. 7035-7046
12 p.
artikel
124 Generation of heterogeneous memory T cells by live attenuated tularemia vaccine in humans Salerno-Gonçalves, Rosangela
2009
28 Supplement 1 p. 195-206
12 p.
artikel
125 Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate Singh, Balwan
2010
28 Supplement 1 p. 2580-2592
13 p.
artikel
126 Girls’ preferences for HPV vaccination: A discrete choice experiment de Bekker-Grob, Esther W.
2010
28 Supplement 1 p. 6692-6697
6 p.
artikel
127 Heat-stable measles vaccine produced by spray drying Ohtake, Satoshi
2010
28 Supplement 1 p. 1275-1284
10 p.
artikel
128 Heterologous HIV-based lentiviral/adenoviral vectors immunizations result in enhanced HIV-specific immunity Asefa, Benyam
2010
28 Supplement 1 p. 3617-3624
8 p.
artikel
129 High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects Potsch, D.V.
2010
28 Supplement 1 p. 1447-1450
4 p.
artikel
130 HIV-1 assembly at the plasma membrane Ono, Akira
2010
28 Supplement 1 p. B55-B59
nvt p.
artikel
131 HIV-2 capsids distinguish high and low virus load patients in a West African community cohort Onyango, Clayton O.
2010
28 Supplement 1 p. B60-B67
nvt p.
artikel
132 HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen Saenz, R.
2010
28 Supplement 1 p. 7556-7562
7 p.
artikel
133 HSP65 serves as an immunogenic carrier for a diabetogenic peptide P277 inducing anti-inflammatory immune response in NOD mice by nasal administration Liang, Jin
2010
28 Supplement 1 p. 3312-3317
6 p.
artikel
134 HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization D’Antuono, Alejandra
2010
28 Supplement 1 p. 7363-7372
10 p.
artikel
135 Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans Tan, Tze Guan
2010
28 Supplement 1 p. 3977-3989
13 p.
artikel
136 IFN-γ-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer Martini, Matteo
2010
28 Supplement 1 p. 3548-3557
10 p.
artikel
137 Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: Results from the EBMT IDWP01 trial Cordonnier, Catherine
2010
28 Supplement 1 p. 2730-2734
5 p.
artikel
138 Immunity to Trop-1, a newly identified breast cancer antigen, inhibits the growth of breast cancer in mice Lee, Byeong C.
2010
28 Supplement 1 p. 7757-7763
7 p.
artikel
139 Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer Kalthoff, Donata
2010
28 Supplement 1 p. 5871-5877
7 p.
artikel
140 Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1 Khattar, Sunil K.
2010
28 Supplement 1 p. 3159-3170
12 p.
artikel
141 Immunization with the attenuated plasmidless Chlamydia trachomatis L2(25667R) strain provides partial protection in a murine model of female genitourinary tract infection Olivares-Zavaleta, Norma
2010
28 Supplement 1 p. 1454-1462
9 p.
artikel
142 Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial Roman, François
2010
28 Supplement 1 p. 1740-1745
6 p.
artikel
143 Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents Lu, Chun-Yi
2010
28 Supplement 1 p. 5864-5870
7 p.
artikel
144 Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10–45 years Tregnaghi, Miguel W.
2010
28 Supplement 1 p. 3595-3601
7 p.
artikel
145 Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age Kaltenböck, A.
2010
28 Supplement 1 p. 834-839
6 p.
artikel
146 Immunogenicity and safety of the human rotavirus vaccine Rotarix™ co-administered with routine infant vaccines following the vaccination schedules in Europe Vesikari, Timo
2010
28 Supplement 1 p. 5272-5279
8 p.
artikel
147 Immunogenicity and safety study of Indirab: A Vero cell based chromatographically purified human rabies vaccine Sampath, Gadey
2010
28 Supplement 1 p. 4086-4090
5 p.
artikel
148 Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2–10 years of age Black, S.
2010
28 Supplement 1 p. 657-663
7 p.
artikel
149 Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves Xue, Wenzhi
2010
28 Supplement 1 p. 3784-3792
9 p.
artikel
150 Immunogenic properties of a recombinant fusion protein containing the C-terminal 19kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium Bargieri, Daniel Y.
2010
28 Supplement 1 p. 2818-2826
9 p.
artikel
151 Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory Stenger, Rachel M.
2010
28 Supplement 1 p. 6637-6646
10 p.
artikel
152 Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules Harvey, Ruth
2010
28 Supplement 1 p. 8008-8014
7 p.
artikel
153 Inactivation of formyltransferase (wbkC) gene generates a Brucella abortus rough strain that is attenuated in macrophages and in mice Lacerda, Thaís Lourdes Santos
2010
28 Supplement 1 p. 5627-5634
8 p.
artikel
154 Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing α-gal epitopes Abdel-Motal, Ussama M.
2010
28 Supplement 1 p. 1758-1765
8 p.
artikel
155 Induction of anti-Tat neutralizing antibodies by the CyaA vector targeting dendritic cells: Influence of the insertion site and of the delivery of multicopies of the dominant Tat B-cell epitope Fayolle, Catherine
2010
28 Supplement 1 p. 6930-6941
12 p.
artikel
156 Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes Brave, Andreas
2010
28 Supplement 1 p. 2080-2087
8 p.
artikel
157 Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant Zhao, Guangyu
2010
28 Supplement 1 p. 7233-7240
8 p.
artikel
158 Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles Saluja, V.
2010
28 Supplement 1 p. 7963-7969
7 p.
artikel
159 Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children Lum, Lucy Chai See
2010
28 Supplement 1 p. 1566-1574
9 p.
artikel
160 Innate immunity and vaccine Seya, Tsukasa
2010
28 Supplement 1 p. 8041-8042
2 p.
artikel
161 In silico DNA vaccine designing against human papillomavirus (HPV) causing cervical cancer Gupta, Shishir Kumar
2009
28 Supplement 1 p. 120-131
12 p.
artikel
162 Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara®) Roukens, Anna H.
2010
28 Supplement 1 p. 4288-4293
6 p.
artikel
163 Intranasal immunization with Leish-111f induces IFN-γ production and protects mice from Leishmania major infection Sakai, Shun-ichi
2010
28 Supplement 1 p. 2207-2213
artikel
164 In vivo electroporation enhances the potency of poly-lactide co-glycolide (PLG) plasmid DNA immunization Barbon, Christine M.
2010
28 Supplement 1 p. 7852-7864
13 p.
artikel
165 Isolation and analysis of the vaccine potential of an attenuated Edwardsiella tarda strain Sun, Yun
2010
28 Supplement 1 p. 6344-6350
7 p.
artikel
166 J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells Taylor, P.R.
2010
28 Supplement 1 p. 5533-5542
10 p.
artikel
167 Knowledge and acceptability of the HPV vaccine by school children and their parents in Birmingham Das, A.
2010
28 Supplement 1 p. 1440-1446
7 p.
artikel
168 Lack of pneumococcal carriage in the hospitalised elderly Ridda, I.
2010
28 Supplement 1 p. 3902-3904
3 p.
artikel
169 Liposomal gD ectodomain (gD1–306) vaccine protects against HSV2 genital or rectal infection of female and male mice Olson, K.
2009
28 Supplement 1 p. 548-560
13 p.
artikel
170 Liposomal oral DNA vaccine (mycobacterium DNA) elicits immune response Wang, Danan
2010
28 Supplement 1 p. 3134-3142
9 p.
artikel
171 Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve Cox, Sarah J.
2010
28 Supplement 1 p. 2318-2322
5 p.
artikel
172 Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1 Feunou, Pascal Feunou
2010
28 Supplement 1 p. 7047-7053
7 p.
artikel
173 Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence Song, Joon Young
2010
28 Supplement 1 p. 3929-3935
7 p.
artikel
174 Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1–11 years Marshall, Helen
2010
28 Supplement 1 p. 4411-4415
5 p.
artikel
175 Lymphadenitis caused by H1N1 vaccination: Case report Toy, Hatice
2010
28 Supplement 1 p. 2158-2160
artikel
176 MCV vaccination in the presence of vaccine-associated Guillain–Barré Syndrome risk: A decision analysis approach Cho, Bo-Hyun
2010
28 Supplement 1 p. 817-822
6 p.
artikel
177 Memory B and T cell responses induced by serotype 4 Streptococcus pneumoniae vaccines: Longitudinal analysis comparing responses elicited by free polysaccharide, conjugate and carrier Deauvieau, Florence
2009
28 Supplement 1 p. 576-582
7 p.
artikel
178 Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster Brisson, Marc
2010
28 Supplement 1 p. 3385-3397
13 p.
artikel
179 Modeling the national pediatric vaccine stockpile: Supply shortages, health impacts and cost consequences Shrestha, Sundar S.
2010
28 Supplement 1 p. 6318-6332
15 p.
artikel
180 Modelling the effect of conjugate vaccines in pneumococcal disease: Cohort or population models? Standaert, Baudouin
2010
28 Supplement 1 p. G30-G38
nvt p.
artikel
181 Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates Hooper, Jay W.
2009
28 Supplement 1 p. 494-511
18 p.
artikel
182 Mucosal HIV vaccines: A holy grail or a dud? Azizi, Ali
2010
28 Supplement 1 p. 4015-4026
12 p.
artikel
183 Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen Jain, Sumiti
2010
28 Supplement 1 p. 7070-7080
11 p.
artikel
184 Murine neutralizing antibody response and toxicity to synthetic peptides derived from E1 and E2 proteins of hepatitis C virus El-Awady, Mostafa K.
2010
28 Supplement 1 p. 8338-8344
7 p.
artikel
185 Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation Paik, Tae-Hyun
2010
28 Supplement 1 p. 7873-7880
8 p.
artikel
186 National Immunization Technical Advisory Groups (NITAGs): Guidance for their establishment and strengthening Duclos, Philippe
2010
28 Supplement 1 p. A18-A25
nvt p.
artikel
187 National influenza surveillance in Vietnam, 2006–2007 Nguyen, Hien T.
2009
28 Supplement 1 p. 398-402
5 p.
artikel
188 Natural Japanese encephalitis virus infection among humans in west and east Japan shows the need to continue a vaccination program Konishi, Eiji
2010
28 Supplement 1 p. 2664-2670
7 p.
artikel
189 Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions Goswami, Shyamal
2010
28 Supplement 1 p. 1241-1252
12 p.
artikel
190 Neutralizing antibodies in SIV control: Co-impact with T cells Yamamoto, Hiroyuki
2010
28 Supplement 1 p. B13-B17
nvt p.
artikel
191 No between-pen transmission of foot-and-mouth disease virus in vaccinated pigs van Roermund, H.J.W.
2010
28 Supplement 1 p. 4452-4461
10 p.
artikel
192 Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7 Adachi, Katsuyuki
2010
28 Supplement 1 p. 2810-2817
8 p.
artikel
193 Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries Talbird, Sandra E.
2010
28 Supplement 1 p. G23-G29
nvt p.
artikel
194 Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine Bridgeman, Anne
2009
28 Supplement 1 p. 474-483
10 p.
artikel
195 Paclitaxel acts as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice Yuan, Lin
2010
28 Supplement 1 p. 4402-4410
9 p.
artikel
196 Pandemic influenza in Canadian children: A summary of hospitalized pediatric cases Bettinger, Julie A.
2010
28 Supplement 1 p. 3180-3184
5 p.
artikel
197 Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand Poovorawan, Yong
2010
28 Supplement 1 p. 730-736
7 p.
artikel
198 Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines Chuck, Anderson W.
2010
28 Supplement 1 p. 5485-5490
6 p.
artikel
199 Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin Smith, Larry R.
2010
28 Supplement 1 p. 2565-2572
8 p.
artikel
200 Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults Pierce, Mark A.
2010
28 Supplement 1 p. 2236-2242
artikel
201 Porcine lactoferrin administration enhances peripheral lymphocyte proliferation and assists infectious bursal disease vaccination in native chickens Hung, Che-Ming
2010
28 Supplement 1 p. 2895-2902
8 p.
artikel
202 Positive effect of the introduction of Haemophilus influenzae type b vaccination in the expanded program on immunization in Cameroon Massenet, Denis
2010
28 Supplement 1 p. 6404-6405
2 p.
artikel
203 Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom Andrews, Nick
2010
28 Supplement 1 p. 7215-7220
6 p.
artikel
204 Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer Krashias, George
2010
28 Supplement 1 p. 2482-2489
8 p.
artikel
205 Potent cross-reactive immune response against the wild-type and drug-resistant forms of HIV reverse transcriptase after the chimeric gene immunization Starodubova, Elizaveta
2010
28 Supplement 1 p. 1975-1986
12 p.
artikel
206 Predictors of universal influenza vaccination uptake in grades 1 and 2 Toronto school children: Effective vaccination strategies should not end with at risk children Foty, Richard G.
2010
28 Supplement 1 p. 6518-6522
5 p.
artikel
207 Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand Newman, Peter A.
2010
28 Supplement 1 p. 958-964
7 p.
artikel
208 Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study Leroux-Roels, Isabel
2010
28 Supplement 1 p. 849-857
9 p.
artikel
209 Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage Cai, Ying
2010
28 Supplement 1 p. 2046-2052
7 p.
artikel
210 Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein Zhou, Xuemei
2010
28 Supplement 1 p. 3990-3996
7 p.
artikel
211 Protective immune responses elicited by immunization with a chimeric blood-stage malaria vaccine persist but are not boosted by Plasmodium yoelii challenge infection Alaro, James R.
2010
28 Supplement 1 p. 6876-6884
9 p.
artikel
212 Protein typing of major outer membrane lipoproteins from Chinese pathogenic Leptospira spp. and characterization of their immunogenicity Luo, Dongjiao
2009
28 Supplement 1 p. 243-255
13 p.
artikel
213 Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice Little, S.F.
2010
28 Supplement 1 p. 934-939
6 p.
artikel
214 Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIVmac251 challenge Faul, Elizabeth J.
2009
28 Supplement 1 p. 299-308
10 p.
artikel
215 Racial disparities in diarrhea-associated hospitalizations among children in five US States, before and after introduction of rotavirus vaccine Yen, Catherine
2010
28 Supplement 1 p. 7423-7426
4 p.
artikel
216 Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers Bernstein, David I.
2009
28 Supplement 1 p. 484-493
10 p.
artikel
217 Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies Klein, Nicola P.
2010
28 Supplement 1 p. 1062-1068
7 p.
artikel
218 Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection Cummings, James F.
2010
28 Supplement 1 p. 5135-5144
10 p.
artikel
219 Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice Ranganathan, Uma Devi K.
2009
28 Supplement 1 p. 152-161
10 p.
artikel
220 Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques Traina-Dorge, V.
2010
28 Supplement 1 p. 6483-6490
8 p.
artikel
221 Reconstructing the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC in East Asia: The relevance of genetic diversity and phylodynamics for vaccine strategies Takebe, Yutaka
2010
28 Supplement 1 p. B39-B44
nvt p.
artikel
222 Reduced immune reaction prevents immunopathology after challenge with avian influenza virus: A transcriptomics analysis of adjuvanted vaccines Reemers, Sylvia S.
2010
28 Supplement 1 p. 6351-6360
10 p.
artikel
223 Reduced risk of hospitalization associated with influenza vaccination in Canada Chen, Yue
2010
28 Supplement 1 p. 2290-2295
6 p.
artikel
224 Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine Chang, Hwa-Gan H.
2010
28 Supplement 1 p. 754-758
5 p.
artikel
225 Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA Regev-Yochay, Gili
2010
28 Supplement 1 p. 4842-4846
5 p.
artikel
226 Regulation of the activity of an adeno-associated virus vector cancer vaccine administered with synthetic Toll-like receptor agonists Triozzi, Pierre L.
2010
28 Supplement 1 p. 7837-7843
7 p.
artikel
227 Re: Misleading comments in Ranganathan et al. “Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice” Kernodle, Douglas S.
2010
28 Supplement 1 p. 2064-2065
2 p.
artikel
228 Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit Valentin, Antonio
2010
28 Supplement 1 p. 1962-1974
13 p.
artikel
229 Report of the international forum on pandemic influenza 2010 Varella, Andre
2010
28 Supplement 1 p. 7579-7582
4 p.
artikel
230 Residual economic burden of Streptococcus pneumoniae- and nontypeable Haemophilus influenzae- associated disease following vaccination with PCV-7: A multicountry analysis Talbird, Sandra E.
2010
28 Supplement 1 p. G14-G22
nvt p.
artikel
231 Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1 Sealy, R.
2010
28 Supplement 1 p. 6749-6756
8 p.
artikel
232 SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model Sharma, Rajesh K.
2010
28 Supplement 1 p. 5794-5802
9 p.
artikel
233 Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO® (IC51), in 6 months of follow-up Dubischar-Kastner, Katrin
2010
28 Supplement 1 p. 6463-6469
7 p.
artikel
234 Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults Laurent, Philippe E.
2010
28 Supplement 1 p. 5850-5856
7 p.
artikel
235 Safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and Haemophilus influenzae Type b combination vaccine compared with separate administration of licensed equivalent vaccines in Chinese infants and toddlers for primary and booster immunization Li, Guifan
2010
28 Supplement 1 p. 4215-4223
9 p.
artikel
236 Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults Treanor, John J.
2010
28 Supplement 1 p. 8268-8274
7 p.
artikel
237 Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers Tribble, D.
2010
28 Supplement 1 p. 6076-6085
10 p.
artikel
238 Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults Frey, Sharon E.
2010
28 Supplement 1 p. 6367-6373
7 p.
artikel
239 Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines Arguedas, A.
2010
28 Supplement 1 p. 3171-3179
9 p.
artikel
240 Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy Russell, F.M.
2010
28 Supplement 1 p. 3086-3094
9 p.
artikel
241 Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulations Nicholson, Karl G.
2009
28 Supplement 1 p. 171-178
8 p.
artikel
242 Safety profile of live varicella virus vaccine (Oka/Merck): Five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP) Goulleret, Nicolas
2010
28 Supplement 1 p. 5878-5882
5 p.
artikel
243 Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster Mills, Richard
2010
28 Supplement 1 p. 4204-4209
6 p.
artikel
244 Seasonal influenza vaccinations: specialized products for different target groups Monto, Arnold S.
2010
28 Supplement 1 p. D14-D23
nvt p.
artikel
245 Serologic testing to verify the immune status of internationally adopted children against vaccine preventable diseases Staat, Mary Allen
2010
28 Supplement 1 p. 7947-7955
9 p.
artikel
246 Serotype distribution of invasive pneumococcal disease during the first 60 days of life Imöhl, Matthias
2010
28 Supplement 1 p. 4758-4762
5 p.
artikel
247 Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use Aguiar, Sandra I.
2010
28 Supplement 1 p. 5167-5173
7 p.
artikel
248 Smell impairment after tick-borne encephalitis vaccination: Case report Vodička, J.
2010
28 Supplement 1 p. 886-888
3 p.
artikel
249 Species-specific CD1-restricted innate immunity for the development of HIV vaccine Takahashi, Hidemi
2010
28 Supplement 1 p. B3-B7
nvt p.
artikel
250 Staphylococcus aureus vaccine for orthopedic patients: An economic model and analysis Lee, Bruce Y.
2010
28 Supplement 1 p. 2465-2471
7 p.
artikel
251 Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems Leroux-Roels, Isabel
2010
28 Supplement 1 p. 7016-7024
9 p.
artikel
252 Structure–activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2 Zaman, Mehfuz
2010
28 Supplement 1 p. 2243-2248
artikel
253 Subcutaneous inoculation of a whole virus particle vaccine prepared from a non-pathogenic virus library induces protective immunity against H7N7 highly pathogenic avian influenza virus in cynomolgus macaques Itoh, Yasushi
2010
28 Supplement 1 p. 780-789
10 p.
artikel
254 Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract Hervouet, Catherine
2010
28 Supplement 1 p. 5582-5590
9 p.
artikel
255 Systematic review of interventions to increase influenza vaccination rates of those 60 years and older Thomas, Roger E.
2010
28 Supplement 1 p. 1684-1701
18 p.
artikel
256 Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques Kraynyak, Kimberly A.
2010
28 Supplement 1 p. 1942-1951
10 p.
artikel
257 Tailoring subunit vaccine immunogenicity: Maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1 Douglas, Alexander D.
2010
28 Supplement 1 p. 7167-7178
12 p.
artikel
258 Targeted microbeads for attraction and induction of specific innate immune response in the tumor microenvironment Shahar, Ehud
2010
28 Supplement 1 p. 7279-7287
9 p.
artikel
259 T cell-based functional cDNA library screening identified SEC14-like 1a carboxy-terminal domain as a negative regulator of human immunodeficiency virus replication Urano, Emiko
2010
28 Supplement 1 p. B68-B74
nvt p.
artikel
260 TC83 replicon vectored vaccine provides protection against Junin virus in guinea pigs Seregin, Alexey V.
2010
28 Supplement 1 p. 4713-4718
6 p.
artikel
261 Temporal changes in the gene signatures of BCG-vaccinated guinea pigs in response to different mycobacterial antigens Tree, Julia A.
2010
28 Supplement 1 p. 7979-7986
8 p.
artikel
262 The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice Chen, Xiaohua
2010
28 Supplement 1 p. 3913-3919
7 p.
artikel
263 The effects of a novel adjuvant complex/Eimeria profilin vaccine on the intestinal host immune response against live E. acervulina challenge infection Lee, Sung-Hyen
2010
28 Supplement 1 p. 6498-6504
7 p.
artikel
264 The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox Heinsbroek, Ellen
2010
28 Supplement 1 p. 3778-3783
6 p.
artikel
265 The potential economic value of a Staphylococcus aureus vaccine for neonates Lee, Bruce Y.
2010
28 Supplement 1 p. 4653-4660
8 p.
artikel
266 The potential global market size and public health value of an HIV-1 vaccine in a complex global market Marzetta, Carol A.
2010
28 Supplement 1 p. 4786-4797
12 p.
artikel
267 The potential value of Clostridium difficile vaccine: An economic computer simulation model Lee, Bruce Y.
2010
28 Supplement 1 p. 5245-5253
9 p.
artikel
268 The preventive phase I trial with the HIV-1 Tat-based vaccine Ensoli, Barbara
2009
28 Supplement 1 p. 371-378
8 p.
artikel
269 The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120 Hioe, Catarina E.
2009
28 Supplement 1 p. 352-360
9 p.
artikel
270 Th2-polarisation of cellular immune memory to neonatal pertussis vaccination White, Olivia J.
2010
28 Supplement 1 p. 2648-2652
5 p.
artikel
271 Three novel NY-ESO-1 epitopes bound to DRB1*0803, DQB1*0401 and DRB1*0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patients Mizote, Yu
2010
28 Supplement 1 p. 5338-5346
9 p.
artikel
272 Transgenic Plasmodium that expresses HIV-1 Gag elicits immunity and protects mice against vaccinia virus-gag and malarial parasites Jiang, Bo
2010
28 Supplement 1 p. 7915-7922
8 p.
artikel
273 Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE Trigo, Joelma
2010
28 Supplement 1 p. 3333-3340
8 p.
artikel
274 Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis Durantez, Maika
2010
28 Supplement 1 p. 7146-7154
9 p.
artikel
275 Use of the Australian Childhood Immunisation Register for vaccine safety data linkage Gold, Michael
2010
28 Supplement 1 p. 4308-4311
4 p.
artikel
276 Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: Meeting at the Crossroads Madore, Dace V.
2010
28 Supplement 1 p. 4539-4547
9 p.
artikel
277 Vaccination against tick-borne encephalitis virus tests specific IgG production ability in patients under immunoglobulin substitution therapy Seidel, Markus G.
2010
28 Supplement 1 p. 6621-6626
6 p.
artikel
278 Vaccination of commercial broiler chicks against avian metapneumovirus infection: a comparison of drinking-water, spray and oculo-oral delivery methods Ganapathy, Kannan
2010
28 Supplement 1 p. 3944-3948
5 p.
artikel
279 Vaccination of grouper broodfish (Epinephelus tukula) reduces the risk of vertical transmission by nervous necrosis virus Kai, Yu-Hsuan
2010
28 Supplement 1 p. 996-1001
6 p.
artikel
280 Vaccination strategies for managing brucellosis in Yellowstone bison Treanor, John J.
2010
28 Supplement 1 p. F64-F72
nvt p.
artikel
281 Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects Howles, Sarah
2010
28 Supplement 1 p. 7306-7312
7 p.
artikel
282 Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras Ellingson, Joshua S.
2010
28 Supplement 1 p. 2679-2686
8 p.
artikel
283 Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity Hu, Biliang
2010
28 Supplement 1 p. 6675-6683
9 p.
artikel
284 Viral reservoir is suppressed but not eliminated by CD8 vaccine specific lymphocytes Yin, Jiangmei
2010
28 Supplement 1 p. 1924-1931
8 p.
artikel
285 Yellow fever vaccination coverage among children in Brazilian capitals Veras, Maria Amélia S.M.
2010
28 Supplement 1 p. 6478-6482
5 p.
artikel
                             285 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland